3 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow Sabril: new trials by email Literature Review of Sabril trials Research Report on Sabril
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vigabatrin and Insulin Sensitivity Vigabatrin - NAFLD, Obesity | Phase 2 | Completed | Washington University School of Medicine | 4 | 2021-08-23 | 2025-01-14 |
| Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex Early Vigabatrin, Delayed Vigabatrin (Placebo) - Tuberous Sclerosis Complex | Phase 2 | Completed | Martina Bebin | 84 | 2016-12-01 | 2024-08-19 |
| Vigabatrin for Cocaine and Alcohol Dependence Vigabatrin, Placebo - Alcoholism, Cocaine Dependence | Phase 2 | Terminated | University of Pennsylvania | 32 | 2011-04-01 | 2019-09-06 |
| Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence Vigabatrin, Placebo, Group therapy - Cocaine Dependence | Phase 2 | Completed | NYU Langone Health | 100 | 2007-04-01 | 2008-04-11 |
Cocaine-Related Disorders (2) · Alcoholism (1) · Behavior, Addictive (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Tuberous Sclerosis (1)
Martina Bebin (1) · NYU Langone Health (1) · University of Pennsylvania (1) · Washington University School of Medicine (1)
United States (3) · Mexico (1)
Emilia Figueroa, M.D. (1) · Jonathan D Brodie, Ph.D., M.D. (1) · Kyle M Kampman, M.D. (1) · Martina Bebin, MD, MPA (1) · Samuel Klein, MD (1)
PMID 19651710, PMID 31912454, PMID 37638552
P50DA012756 (1), U01NS092595 (1)